Uploaded by talbot

6 SLIDES

221 VUES

70LIKES

ATP III Guidelines Population Groups

DESCRIPTION

Special Considerations for Different Population Groups. Younger AdultsMen 20

ATP III Guidelines Population Groups

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

atp iii guidelines adherence

Interventions to Improve Adherence. Focus on the patientSimplify medication regimensProvide explicit patient instruction and use good counseling techniques to teach the patient how to follow the prescribed treatmentEncourage the use of prompts to help patients remember treatment regimensUse systems to reinforce adherence and maintain contact with the patient.

624 views • 5 slides

ATP III Guidelines Drug Therapy

Drug Therapy. HMG CoA Reductase Inhibitors (Statins)Reduce LDL-C 18

518 views • 18 slides

NCEP ATP III Cholesterol Guidelines and Updates

NCEP ATP III Cholesterol Guidelines and Updates. Anoop Agrawal, M.D. Med-Peds Continuity Clinic Baylor College of Medicine. Background. Adult Treatment Panel of the National Cholesterol Education Program issued their third guideline for cholesterol management in 2001 - known as ATP III .

988 views • 26 slides

ATP III Guidelines Detection and Evaluation

Categories of Risk Factors. Major, independent risk factorsLife-habit risk factorsEmerging risk factors. Life-Habit Risk Factors. Obesity (BMI ? 30)Physical inactivityAtherogenic diet. Emerging Risk Factors. Lipoprotein (a)HomocysteineProthrombotic factorsProinflammatory factorsImpaired fasting glucose Subclinical atherosclerosis.

442 views • 14 slides

Adult Treatment Panel III ATP III Guidelines Erminia Guarneri, MD, FACC October 2001

New Features of ATP III. Focus on Multiple Risk FactorsDiabetes: CHD risk equivalentFramingham projections of 10-year CHD riskIdentify certain patients with multiple risk factors for more intensive treatmentMultiple metabolic risk factors (metabolic syndrome)Intensified therapeutic lifestyle changes.

965 views • 67 slides

ATP III Guidelines Therapeutic Lifestyle Changes TLC

Therapeutic Lifestyle Changes in LDL-Lowering Therapy. Major FeaturesTLC DietReduced intake of cholesterol-raising nutrients (same as previous Step II Diet)Saturated fats <7% of total caloriesDietary cholesterol <200 mg per dayLDL-lowering therapeutic optionsPlant stanols/sterols (2 g per day)Viscous (soluble) fiber (10

453 views • 7 slides

III. POPULATION

III. POPULATION. Doris V and Ne’Shonda D. POPULATION BIOLOGY. Population Biology. Exponential Growth: has no limits and has a J curve when graphed (population size can be small at first but quickly increase in a short time)

471 views • 31 slides

Population Characteristics Population Part III

Population Characteristics Population Part III. World Population Growth Birth rate ( b ) − death rate ( d ) = rate of natural increase ( r ). Population Characteristics. Crude Birth Rate (CBR) Crude Death Rate (CDR) Natural Increase Rate (NIR) Doubling Time Total Fertility Rate (TFR)

323 views • 18 slides

Asian Population Groups

Asian Population Groups. Sabrina Ho AMAT API Committee Chair, DMV and Media Relations Specialist, OneLegacy. Communities in Transition: Asian Population. Sabrina Ho AMAT API Committee Chair. Asian Population Projection. Immigration. Top 20 API Groups. Filipino. Focus.

629 views • 34 slides

ATP III Guidelines Goals and Treatment Overview

ATP III Guidelines Goals and Treatment Overview. Primary Prevention With LDL-Lowering Therapy. Public Health Approach Reduced intakes of saturated fat and cholesterol Increased physical activity Weight control. Primary Prevention . Goals of Therapy Long-term prevention (&gt;10 years)

293 views • 17 slides

ATP III Guidelines Detection and Evaluation

ATP III Guidelines Detection and Evaluation. Categories of Risk Factors. Major, independent risk factors Life-habit risk factors Emerging risk factors. Life-Habit Risk Factors. Obesity (BMI  30) Physical inactivity Atherogenic diet. Emerging Risk Factors. Lipoprotein (a) Homocysteine

345 views • 14 slides

ATP III Guidelines Drug Therapy

ATP III Guidelines Drug Therapy. Drug Therapy. HMG CoA Reductase Inhibitors (Statins) Reduce LDL-C 18–55% &amp; TG 7–30% Raise HDL-C 5–15% Major side effects Myopathy Increased liver enzymes Contraindications Absolute: liver disease Relative: use with certain drugs.

400 views • 19 slides

ATP III Guidelines Specific Dyslipidemias

ATP III Guidelines Specific Dyslipidemias. Specific Dyslipidemias: Very High LDL Cholesterol ( 190 mg/dL). Causes and Diagnosis Genetic disorders Monogenic familial hypercholesterolemia Familial defective apolipoprotein B-100 Polygenic hypercholesterolemia

375 views • 13 slides

Adult Treatment Panel III (ATP III) Guidelines

Adult Treatment Panel III (ATP III) Guidelines. National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (ATP III). Members Scott M. Grundy, M.D., Ph.D. (Chair)

965 views • 11 slides

Section III Population Ecology

Section III Population Ecology. 鄭先祐生態主張者 Ayo Japalura@hotmail.com. Section Three Population Ecology. Chap.6 Population growth ( 族群成長 ) Chap.7 Physical environment ( 物理環境 ) Chap.8 Competition and coexistence ( 競爭與共存 ) Chap.9 Mutualism ( 共生 ) Chap.10 Predation ( 掠食 )

963 views • 58 slides

ATP III Guidelines Implementation

ATP III Guidelines Implementation. Percent of Adults Who Need Lifestyle and Drug Treatment. CHD and CHD Risk Equivalents 12.1 10.5 10-year risk &gt;20% 2+ Risk Factors 5.5 4.2 10-year risk 10-20% 2+ Risk Factors 7.4 1.4 10-year risk &lt;10% 0-1 Risk Factor 7.9 2.4

186 views • 5 slides

Implications of Recent Clinical Trials for the NCEP ATP III Guidelines

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

432 views • 16 slides

ATP III Guidelines Therapeutic Lifestyle Changes (TLC)

ATP III Guidelines Therapeutic Lifestyle Changes (TLC). Therapeutic Lifestyle Changes in LDL-Lowering Therapy. Major Features TLC Diet Reduced intake of cholesterol-raising nutrients (same as previous Step II Diet) Saturated fats &lt;7% of total calories Dietary cholesterol &lt;200 mg per day

319 views • 7 slides

NCEP ATP III Cholesterol Guidelines and Updates

294 views • 26 slides

Adult Treatment Panel III (ATP III) Guidelines

1.32k views • 103 slides

Section III Population Ecology

624 views • 58 slides

Functional Groups III

Functional Groups III. Functional Groups III. Halogenoalkanes. Organic compounds with one or more halogens in place of hydrogen are called halogenoalkanes or alkyl halides . These compounds are named as alkanes with the halogen as a substituent.

226 views • 20 slides

More Related